Caspase-2 Enzyme Inhibition Shows Promise for Ameliorating Fatty Liver Disease

Researchers have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis (NASH), a chronic and aggressive liver condition.